Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target ...

Piper Sandler Companies (PIPR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

Piper Sandler Companies PIPR has announced a new share repurchase plan. The board of directors has approved the repurchase of up to $150 million worth of shares of PIPR’s outstanding stock.

In a report released today, Thomas Champion from Piper Sandler maintained a Buy rating on Zillow Group Class A (ZG – Research Report), with a ...

In a report released today, Thomas Champion from Piper Sandler reiterated a Hold rating on DoorDash (DASH – Research Report), with a price ...

Fintel reports that on February 5, 2025, Piper Sandler upgraded their outlook for Simon Property Group (WBAG:SPGR) from Neutral to Overweight. There are 2,101 funds or institutions reporting ...

Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently ...

IDEXX Laboratories (NASDAQ:IDXX – Free Report) had its price objective upped by Piper Sandler from $435.00 to $510.00 in a research report report published on Monday morning,Benzinga reports. Piper ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...

Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...

QUALCOMM (NASDAQ:QCOM – Get Free Report) had its price objective decreased by investment analysts at Piper Sandler from ...

Piper Sandler reiterated their overweight rating on shares of Fortinet (NASDAQ:FTNT – Free Report) in a report published on Friday,Benzinga reports. Piper Sandler currently has a $135.00 price ...